ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.

Shinya Fujiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.